| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 576 | 2018 |
| Hypermetabolism in ALS patients: an early and persistent phenomenon C Bouteloup, JC Desport, P Clavelou, N Guy, H Derumeaux-Burel, ... Journal of neurology 256, 1236-1242, 2009 | 381 | 2009 |
| Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ... The Lancet Neurology 17 (10), 895-904, 2018 | 351 | 2018 |
| MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study A Tourbah, C Lebrun-Frenay, G Edan, M Clanet, C Papeix, S Vukusic, ... Multiple Sclerosis Journal 22 (13), 1719-1731, 2016 | 341 | 2016 |
| Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis … BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, ... The Lancet Neurology 18 (1), 46-55, 2019 | 319 | 2019 |
| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 259 | 2018 |
| Application of the formalin test to the study of orofacial pain in the rat P Clavelou, J Pajot, R Dallel, P Raboisson Neuroscience letters 103 (3), 349-353, 1989 | 254 | 1989 |
| Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked … C Lebrun, C Bensa, M Debouverie, S Wiertlevski, D Brassat, J de Seze, ... Archives of neurology 66 (7), 841-846, 2009 | 247 | 2009 |
| Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta … BCV Campbell, WH Van Zwam, M Goyal, BK Menon, DWJ Dippel, ... The Lancet Neurology 17 (1), 47-53, 2018 | 235 | 2018 |
| The orofacial formalin test in rats: effects of different formalin concentrations P Clavelou, R Dallel, T Orliaguet, A Woda, P Raboisson Pain 62 (3), 295-301, 1995 | 232 | 1995 |
| Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques P Amarenco, S Davis, EF Jones, AA Cohen, WD Heiss, M Kaste, ... Stroke 45 (5), 1248-1257, 2014 | 209 | 2014 |
| Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy JM Léger, K Viala, G Nicolas, A Créange, JM Vallat, J Pouget, P Clavelou, ... Neurology 80 (24), 2217-2225, 2013 | 191 | 2013 |
| Acute fulminant demyelinating disease: a descriptive study of 60 patients J de Seze, M Debouverie, H Zephir, C Lebrun, F Blanc, V Bourg, ... Archives of neurology 64 (10), 1426-1432, 2007 | 187 | 2007 |
| Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin R Dallel, P Raboisson, P Clavelou, M Saade, A Woda Pain 61 (1), 11-16, 1995 | 160 | 1995 |
| Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile C Lebrun, C Bensa, M Debouverie, J De Seze, S Wiertlievski, B Brochet, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (2), 195-198, 2008 | 159 | 2008 |
| Cognitive impairment in a population‐based study of patients with multiple sclerosis: differences between late relapsing− remitting, secondary progressive and primary … V Planche, M Gibelin, D Cregut, B Pereira, P Clavelou European journal of neurology 23 (2), 282-289, 2016 | 157 | 2016 |
| A randomised clinical trial comparing interferon-α and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM X Mariette, C Chastang, JP Louboutin, JM Leger, P Clavelou, JC Brouet Journal of Neurology, Neurosurgery & Psychiatry 63 (1), 28-34, 1997 | 156 | 1997 |
| Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial D Cadavid, M Mellion, R Hupperts, KR Edwards, PA Calabresi, J Drulović, ... The Lancet Neurology 18 (9), 845-856, 2019 | 155 | 2019 |
| Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness DC de Andrade, S Jean, P Clavelou, R Dallel, D Bouhassira BMC infectious diseases 10, 1-6, 2010 | 155 | 2010 |
| Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study M Cohen, E Maillart, A Tourbah, J De Seze, S Vukusic, D Brassat, O Anne, ... JAMA neurology 71 (4), 436-441, 2014 | 150 | 2014 |
